Home Cart Sign in  
Chemical Structure| 445430-58-0 Chemical Structure| 445430-58-0

Structure of BMS-345541
CAS No.: 445430-58-0

Chemical Structure| 445430-58-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-345541 dose-dependently inhibits the TNF-α-stimulated phosphorylation of IκBα in THP-1 monocytic cells with an IC50 of ~4 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-345541

CAS No. :445430-58-0
Formula : C14H17N5
M.W : 255.32
SMILES Code : NCCNC1=NC2=C(N3C1=NC=C3C)C=C(C)C=C2
MDL No. :MFCD18089812
InChI Key :PSPFQEBFYXJZEV-UHFFFAOYSA-N
Pubchem ID :9813758

Safety of BMS-345541

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of BMS-345541

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U-2 OS cells 5 µM Inhibition of NFKB signaling pathway, triggering iDISC-mediated cell death PMC10813646
OEC-M1 cells 50 μM Inhibited IGFBP3-induced NF-κB activation and reduced ROS production PMC7955639
TW2.6 cells 50 μM Inhibited IGFBP3-induced NF-κB activation and reduced ROS production PMC7955639
human platelets 4 µM 30 minutes To investigate the effect of BMS-345541 on human platelet activation, results showed that BMS-345541 did not reduce P-selectin surface expression or GPIIb/IIIa activation. PMC7042989
murine platelets 4 µM 30 minutes To investigate the effect of BMS-345541 on murine platelet activation, results showed that BMS-345541 did not reduce P-selectin surface expression or GPIIb/IIIa activation. PMC7042989
C2C12 myotubes 5μM 72 hours BMS-345541 inhibited SAA1-induced NF-κB p65 phosphorylation, inhibited formation of NF-κB-DNA complexes, and attenuated SAA1-induced myotube atrophy PMC7015249
THP-1 cells 25μM BMS-345541 inhibited LPS-induced production of TNF, IL-1β, IL-8, and IL-6 PMC7015249
Primary canine chondrocytes (PCH) 5 µM BMS-345541, as an IKK inhibitor, was used to block the NF-κB pathway, reducing inflaμMation and protecting chondrocytes from inflaμMatory environments. PMC10944933
BMDM 5 µM 6 hours BMS-345541 blocked the NAD+-boosting induced by NRH and the expression of pro-inflaμMatory genes, indicating that IKK regulates NRH-induced NAD+ metabolism and gene expression. PMC8913500

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice Cecal ligation and puncture (CLP) model Oral 300 mg/kg/day Daily, continuous treatment BMS-345541 significantly improved survival and reduced muscle atrophy in septic mice PMC7015249

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.92mL

0.78mL

0.39mL

19.58mL

3.92mL

1.96mL

39.17mL

7.83mL

3.92mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories